Konica Minolta to buy US cancer-testing company
03-Jul-17, Nikkei Asian Review
Japan's Konica Minolta plans to acquire Ambry Genetics of the US, which uses genetic data to screen for cancer. The acquisition is expected to cost an estimated JPY100 billion yen (USD889 million).
%20Konica%20Minolta.jpg "Konica Minolta to buy US cancer testing company (c) Konica Minolta")
Image: Konica Minolta
It is expected to be the office equipment maker's most expensive acquisition - one that it will make by partnering with the public-private Innovation Network Corp of Japan.
Konica has been struggling to boost its flagship multifunctional printer business. The acquisition, though, will bring the company further into the healthcare sector and give it a new revenue source.